Skip to main content

Ross Thomas M.'s Form 4 filing

Maxcyte, Inc.MXCT · filed Apr 12, 2023

Accession no.
0001209191-23-024116
Filed
Apr 12, 2023
Trade date
Apr 10-12, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $70.7K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ross Thomas M.CIK 0001874572Officer (EVP, Global Sales & Marketing)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 10, 2023Common StockMOption exerciseAcquired+100$2.14+$214100Direct
Apr 10, 2023Common StockSSaleDisposed−100$5.00−$5000Direct
Apr 11, 2023Common StockMOption exerciseAcquired+8,451$2.14+$18,085.148,451Direct
Apr 11, 2023Common StockSSaleDisposed−8,451$5.00F2−$42,2550Direct
Apr 12, 2023Common StockMOption exerciseAcquired+5,583$2.14+$11,947.625,583Direct
Apr 12, 2023Common StockSSaleDisposed−5,583$5.00−$27,9150Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 10, 2023Common StockMOption exerciseDisposed−100$0.00$027,902Direct
Apr 11, 2023Common StockMOption exerciseDisposed−8,451$0.00$019,451Direct
Apr 12, 2023Common StockMOption exerciseDisposed−5,583$0.00$013,868Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)